Stock Research for AXIM

AXIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AXIM Stock Chart & Research Data

The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AXIM Due diligence Resources & Stock Charts

The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXIM Detailed Price Forecast - CNN Money CNN View AXIM Detailed Summary - Google Finance
Yahoo View AXIM Detailed Summary - Yahoo! Finance Zacks View AXIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AXIM Trends & Analysis - Trade-Ideas Barrons View AXIM Major Holders - Barrons
NASDAQ View AXIM Call Transcripts - NASDAQ Seeking View AXIM Breaking News & Analysis - Seeking Alpha
Spotlight View AXIM Annual Report - CompanySpotlight.com OTC Report View AXIM OTC Short Report - OTCShortReport.com
TradeKing View AXIM Fundamentals - TradeKing Charts View AXIM SEC Filings - Bar Chart
WSJ View Historical Prices for AXIM - The WSJ Morningstar View Performance/Total Return for AXIM - Morningstar
MarketWatch View the Analyst Estimates for AXIM - MarketWatch CNBC View the Earnings History for AXIM - CNBC
StockMarketWatch View the AXIM Earnings - StockMarketWatch MacroAxis View AXIM Buy or Sell Recommendations - MacroAxis
Bullish View the AXIM Bullish Patterns - American Bulls Short Pains View AXIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AXIM Stock Mentions - StockTwits PennyStocks View AXIM Stock Mentions - PennyStockTweets
Twitter View AXIM Stock Mentions - Twitter Invest Hub View AXIM Investment Forum News - Investor Hub
Yahoo View AXIM Stock Mentions - Yahoo! Message Board Seeking Alpha View AXIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AXIM - SECform4.com Insider Cow View Insider Transactions for AXIM - Insider Cow
CNBC View AXIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXIM - OTC Markets
Yahoo View Insider Transactions for AXIM - Yahoo! Finance NASDAQ View Institutional Holdings for AXIM - NASDAQ


Stock Charts

FinViz View AXIM Stock Insight & Charts - FinViz.com StockCharts View AXIM Investment Charts - StockCharts.com
BarChart View AXIM Stock Overview & Charts - BarChart Trading View View AXIM User Generated Charts - Trading View




Latest Financial News for AXIM


AXIM Biotechnologies Enhances IgE Testing Capabilities; Responds to Global Warming's Impact on Allergy Season
Posted on Tuesday July 26, 2022

SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, announced today that it has launched an enhanced version of its rapid Ocular Immunoglobulin E (IgE) test in response to a study recently published in Nature by researchers at the University of Michigan Department of Climate and Space Sciences and Engineering. The article titled “Projected


AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
Posted on Thursday July 21, 2022

SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, announced today that its CEO John Huemoeller has been featured on the Vision is More Than 20/20™ podcast. The podcast discusses how Dry Eye Disease (DED) is significantly prevalent, especially because of increased electronic device use, surgical mask-wearing during the COVID-19 pandemic, a


AXIM Biotechnologies Publishes Study Highlighting Neutralizing Antibody Levels of Poor Vaccine Responders with a Third COVID-19 Vaccine Dose
Posted on Tuesday July 12, 2022

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their publication in collaboration with researchers at Arizona State University (ASU) entitled, “Third COVID-19 Vaccine Dose Boosts Neutralizing Antibodies in Poor Responders” in Communications Medicine, part of the Nature family of journals. AXIM and ASU performed a clinical study using their co-developed r


AXIM Launches New Eye Care Website; Establishes Platform for Commercialization
Posted on Thursday June 02, 2022

SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, today announced the launch of its new mobile-optimized website designed to provide doctors, researchers and other medical professionals with tailored, timely information and resources that will enable them to make informed decisions when purchasing AXIM’s proprietary diagnostic tests. This


Stock Market & Investing Books

Enter a stock symbol to view the stock details.